Literature DB >> 25449256

Molecular characterization of macrolide resistance of a Mycoplasma pneumoniae strain that developed during therapy of a patient with pneumonia.

Roger Dumke1, Simone Stolz2, Enno Jacobs3, Thomas Juretzek4.   

Abstract

The development of macrolide resistance that occurred during 3 days of therapy with azithromycin to treat Mycoplasma pneumoniae pneumonia in a paediatric patient is reported. After extended molecular characterization of strains, the parallel occurrence of clones showing the non-mutated wild-type 23S rRNA sequence as well as mutations A2063G and A2064G, which are both responsible for phenotypic resistance, was confirmed for the first time.
Copyright © 2014 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Community-acquired pneumonia; Mycoplasma pneumoniae; Typing Macrolide resistance

Mesh：

Substances：

Year:  2014        PMID： 25449256     DOI： 10.1016/j.ijid.2014.07.014

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN： 1201-9712            Impact factor:   3.623


  16 in total

1.  Long-Term Low Rate of Macrolide-Resistant Mycoplasma pneumoniae Strains in Germany.

Authors:  Roger Dumke; Thomas Ziegler
Journal:  Antimicrob Agents Chemother       Date:  2019-04-25       Impact factor: 5.191

Review 2.  Mycoplasma pneumoniae from the Respiratory Tract and Beyond.

Authors:  Ken B Waites; Li Xiao; Yang Liu; Mitchell F Balish; T Prescott Atkinson
Journal:  Clin Microbiol Rev       Date:  2017-07       Impact factor: 26.132

3.  Epidemiology and Molecular Characteristics of Mycoplasma pneumoniae During an Outbreak of M. pneumoniae-associated Stevens-Johnson Syndrome.

Authors:  Louise K Francois Watkins; Daniel Olson; Maureen H Diaz; Xia Lin; Alicia Demirjian; Alvaro J Benitez; Jonas M Winchell; Christine C Robinson; Kirk A Bol; Mary P Glodé; Samuel R Dominguez; Lisa A Miller; Preeta K Kutty
Journal:  Pediatr Infect Dis J       Date:  2017-06       Impact factor: 2.129

4.  Macrolide-Resistant Mycoplasma pneumoniae in the United States as Determined from a National Surveillance Program.

Authors:  K B Waites; A Ratliff; D M Crabb; L Xiao; X Qin; R Selvarangan; Y-W Tang; X Zheng; J Dien Bard; T Hong; M Prichard; E Brooks; S Dallas; L Duffy; E Mixon; K B Fowler; T P Atkinson
Journal:  J Clin Microbiol       Date:  2019-10-23       Impact factor: 5.948

5.  Clonal Spread of a Unique Strain of Macrolide-Resistant Mycoplasma Pneumoniae Within a Single Family in Italy.

Authors:  Maria Chironna; Daniela Loconsole; Anna Lisa De Robertis; Anna Morea; Egidio Scalini; Michele Quarto; Silvio Tafuri; Cinzia Germinario; Mariano Manzionna
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

Review 6.  The Evolution of Advanced Molecular Diagnostics for the Detection and Characterization of Mycoplasma pneumoniae.

Authors:  Maureen H Diaz; Jonas M Winchell
Journal:  Front Microbiol       Date:  2016-03-08       Impact factor: 5.640

7.  Molecular Detection and Characterization of Mycoplasma pneumoniae Among Patients Hospitalized With Community-Acquired Pneumonia in the United States.

Authors:  Maureen H Diaz; Alvaro J Benitez; Kristen E Cross; Lauri A Hicks; Preeta Kutty; Anna M Bramley; James D Chappell; Weston Hymas; Anami Patel; Chao Qi; Derek J Williams; Sandra R Arnold; Krow Ampofo; Wesley H Self; Carlos G Grijalva; Evan J Anderson; Jonathan A McCullers; Andrew T Pavia; Richard G Wunderink; Kathryn M Edwards; Seema Jain; Jonas M Winchell
Journal:  Open Forum Infect Dis       Date:  2015-07-16       Impact factor: 3.835

8.  Analysis of clinical value of CT in the diagnosis of pediatric pneumonia and mycoplasma pneumonia.

Authors:  Liang Gong; Chong-Lin Zhang; Qing Zhen
Journal:  Exp Ther Med       Date:  2016-02-15       Impact factor: 2.447

9.  No detection of macrolide-resistant Mycoplasma pneumoniae from Swedish patients, 1996-2013.

Authors:  Karolina Gullsby; Kåre Bondeson
Journal:  Infect Ecol Epidemiol       Date:  2016-06-01

Review 10.  Mycoplasma pneumoniae: Current Knowledge on Macrolide Resistance and Treatment.

Authors:  Sabine Pereyre; Julien Goret; Cécile Bébéar
Journal:  Front Microbiol       Date:  2016-06-22       Impact factor: 5.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.